Home Arena Pharmaceuticals Announces BELVIQ (lorcaserin HCl) New Drug Submission In Canada
 

Keywords :   


Arena Pharmaceuticals Announces BELVIQ (lorcaserin HCl) New Drug Submission In Canada

2013-07-03 06:56:53| drugdiscoveryonline News Articles

Arena Pharmaceuticals, Inc.announced recently that Eisai Limited (based inMississauga, Ontario), a subsidiary of Eisai Inc., has submitted a New Drug Submission (NDS) for BELVIQ™ (lorcaserin HCl) with Health Canada

Tags: canada drug submission arena

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11Costume
24.11BB S604ULS
24.1133
24.11 ElectronicAudioExperimentsDude Incedible
24.11 TC101 5IP 6 NS.NEO 950GH S
24.11
24.11
24.11
More »